Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 3WGI8FOO62

Structure

InChI Key XDKRVNKVAKCFGW-FOCLMDBBSA-N
Smile O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1
InChI
InChI=1S/C20H17ClN2O3/c21-12-6-7-14-16(11-18(20(25)26)22-17(14)10-12)15-8-9-23(19(15)24)13-4-2-1-3-5-13/h1-7,10,18,22H,8-9,11H2,(H,25,26)/b16-15+

Physicochemical Descriptors

Property Name Value
Molecular Formula C20H17ClN2O3
Molecular Weight 368.82
AlogP 3.8
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 2.0
Polar Surface Area 69.64
Molecular species ACID
Aromatic Rings 2.0
Heavy Atoms 26.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Glutamate [NMDA] receptor antagonist PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Tobacco Use Disorder 2 D014029 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEMBL CHEMBL1207366
FDA SRS 3WGI8FOO62
SureChEMBL SCHEMBL5750612